133
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Nuclear morphometric findings in undetermined cytology: A possible clue for prediction of BRAF mutation in papillary thyroid carcinomas

, , , &
Pages 138-144 | Received 15 Nov 2015, Accepted 18 Oct 2016, Published online: 02 Dec 2016

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
  • Cibas ES, Ali SZ. The Bethesta system for reporting thyroid cytopathology. Thyroid. 2009; 19:1159–1165.
  • Chakraborty A, Narkar A, Mukhopadhyaya R, Kane S, D’Cruz A, Rajan MG. BRAF V600E mutation in papillary thyroid carcinoma: Significant association with node metastases and extra thyroidal invasion. Endocr Pathol. 2012;23:83–93.
  • Bhaijee F, Nikiforov YE. Molecular analysis of thyroid tumors. Endocr Pathol. 2011;22:126–133.
  • Li C, Aragon Han P, Lee KC, et al. Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers. J Clin Endocrinol Metab. 2013;98:3702–3712.
  • Carr R, Ustun B, Chhieng D, et al. Radiologic and clinical predictors of malignancy in the follicular lesion of undetermined significance of the thyroid. Endoc Pathol. 2013;24:62–70.
  • Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C. BRAF mutation testing of thyroid fine needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Acta Cytologica. 2011;55:570–575.
  • Nikiforov YE, Ohori NP. Papillary carcinoma. In: Nikiforov YE, ed. Diagnostic Pathology and Molecular Genetics of the Thyroid, 2nd edn. Lippincott Williams & Wilkins: Philadelphia; 2012:186–188.
  • Rosai J, Tallini G. Thyroid gland. In: Rosai J, ed. Rosai and Ackerman’s Surgical Pathology, 10th ed. Elsevier; 2011:488–538.
  • Nagashima T, Suzuki M, Oshida M, et al. Morphometry in the cytologic evaluation of thyroid follicular lesions cancer. Cancer Cytopathology. 1998;84:115–118.
  • Priya SS, Sundaram S. Morphology to morphometry in cytological evaluation of thyroid lesions. Journal of Cytology. 2011;28:98–102.
  • Shih SR, Chang YC, Li HY, et al. Preoperative prediction of papillary thyroid carcinoma prognosis with the assistance of computerized morphometry of cytology samples obtained by fine-needle aspiration: Preliminary report. Head & Neck. 2013;35:28–34.
  • Halait H, Demartin K, Shah S, et al. Analytical performance of a real time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma. Diagn Mol Pathol. 2012;21:1–8.
  • Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96:3390–3397.
  • Yassa L, Cibas ES, Benson CB, et al. Longterm assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007;111:508–516.
  • Ohori NP, Singhal R, et al. BRAF mutation detection in indeterminate thyroid cytology specimens: Underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma. Cancer Cytopathol. 2013;121:197–205.
  • Aragon Han P, Olson MT, Fazeli R, et al. The impact of molecular testing on the surgical management of patients with thyroid nodules. Ann Surg Oncol. 2014;21:1862–1869.
  • Karslioğlu Y, Celasun B, Gunhan O. Contribution of morphometry in the differential diagnosis of fine needle thyroid aspirates. Clin Cytomet. 2005;65:22–28.
  • Ehsani L, Cohen C, Fisher KE, Siddiqui MT. BRAF mutations in metastatic malignant melanoma: Comparison of molecular analysis and immunohistochemical expression. Appl Immunohistochem Mol Morphol. 2014;22:648–651.
  • Fisher KE, Neill SG, Ehsani L, Caltharp SA, Siddiqui MT, Cohen C. Immunohistochemical investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies. Appl Immunohistochem Mol Morphol. 2014;22:562–567.
  • Dinges HC, Capper D, Ritz O, et al. Validation of a manual protocol for BRAF V600E mutationspecific immunohistochemistry. Appl Immunohistochem Mol Morphol. 2015; 23:382–388.
  • Barr Fritcher EG, Kipp BR, Slezak JM, et al. Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy. Am J Clin Pathol. 2007;128:272–279.
  • Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma. A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016; 2(8):1023–1029.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.